FindTrial
Sign In

12 months DAPT

DRUG3 trials

Sponsors

Maasstad Hospital, Shanghai MicroPort Medical (Group) Co., Ltd., China National Center for Cardiovascular Diseases

Conditions

Cardiovascular DiseaseCoronary Artery DiseaseDrug-Eluting StentDrug-Eluting StentsDual Antiplatelet TherapyElevated Lipoprotein(a) LevelMyocardial InfarctionPercutaneous Coronary Intervention

Phase 4

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI
CompletedNCT01459627
Maasstad HospitalCardiovascular Disease, Myocardial Infarction
Start: 2011-12-31End: 2017-08-31Target: 1100Updated: 2017-09-07
Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation
NCT03008083
Shanghai MicroPort Medical (Group) Co., Ltd.Drug-Eluting Stents, Percutaneous Coronary Intervention
Start: 2019-01-10End: 2022-10-31Target: 2446Updated: 2020-09-09

Unknown Phase

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
RecruitingNCT06014060
China National Center for Cardiovascular DiseasesCoronary Artery Disease, Drug-Eluting Stent, Dual Antiplatelet Therapy +1
Start: 2025-06-20End: 2028-12-31Target: 3300Updated: 2025-07-18

Related Papers

Three vs 12-month DAPT after implantation of biodegradable-polymer sirolimus-eluting coronary stent: a randomised clinical trial.
2025-12-24
Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial
BMJ Open2019-12-012 citations
Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial
Catheterization and Cardiovascular Interventions2019-07-032 citations
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
BMJ2018-10-02177 citations